Opportunity Information: Apply for CDC RFA PS10 10200501SUPP16
Apply for CDC RFA PS10 10200501SUPP16
- The HHS-CDC in the health sector is offering a public funding opportunity titled "Supporting the Scale up of Comprehensive HIV/AIDS Prevention Services in the Republic of Uganda under PEPFAR" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
- This funding opportunity was created on Dec 14, 2015 and posted on Dec 14, 2015.
- Applicants must submit their applications by Feb 14, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $1,562,149.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Supporting the Scale up of Comprehensive HIV/AIDS Prevention Services in the Republic of Uganda under PEPFAR" is a U.S. government public health funding announcement issued by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (HHS-CDC). It is offered as a discretionary Cooperative Agreement, meaning CDC would not simply provide funds and step back, but would typically remain actively involved through ongoing technical collaboration, monitoring, and program guidance as the work is carried out. The program sits within a health funding activity area (CFDA 93.067) and is positioned under the broader PEPFAR framework, which is the U.S. government initiative supporting HIV prevention, care, and treatment in heavily affected countries, including Uganda.
The purpose of this specific opportunity is focused and practical: it supports the continuation of voluntary medical male circumcision (VMMC) services and, at the same time, aims to strengthen the capacity of district-level health facilities to do better diagnosis and treatment of sexually transmitted infections (STIs). In other words, it is not framed as a brand-new pilot but as a continuation and scale-up effort. VMMC is widely used in HIV prevention programming in high-burden settings because it can reduce the risk of heterosexual acquisition of HIV in men when delivered safely and with appropriate counseling and follow-up. By funding continued VMMC delivery, the announcement supports maintaining service availability, demand creation and client flow, quality assurance, and the clinical systems needed to deliver circumcisions safely at scale.
Alongside VMMC, the announcement emphasizes improving the ability of district health facilities to diagnose and treat STIs. This is an important complement to HIV prevention because untreated STIs can increase the likelihood of HIV transmission and acquisition, and because STI services often serve as an entry point for HIV testing, prevention counseling, and linkage to additional services. Strengthening facility capacity in this context typically points to upgrades in clinical competencies and systems: improving provider training and adherence to national guidelines, strengthening syndromic management and/or laboratory-supported diagnosis where applicable, ensuring consistent availability of essential STI medicines and commodities, improving documentation and reporting, and reinforcing referral pathways for complicated cases. The underlying aim is to move beyond short-term outreach and create more durable service readiness at district facilities, so that STI diagnosis and treatment becomes more reliable, timely, and standardized.
Administratively, the opportunity is identified as Funding Opportunity Number "CDC RFA PS10-10200501SUPP16." The award ceiling is listed as $1,562,149, with an expectation of a single award (ExpectedAwards: 1). This strongly suggests the funding is intended either for one principal implementing partner or for a single prime recipient coordinating a broader network of sub-awards or supported facilities. The opportunity category is "Discretionary," and the eligible applicants field is listed as "Others (see text field entitled Additional Information on Eligibility for clarification)," which indicates eligibility details were defined in the full announcement rather than being limited to a simple category like state governments or universities. The posting and creation dates are both December 14, 2015, and the closing date is February 14, 2016, reflecting a roughly two-month application window.
Taken together, the grant is best understood as a targeted PEPFAR-supported prevention investment in Uganda that combines a proven biomedical HIV prevention intervention (VMMC) with health system strengthening focused on STI services at the district level. The structure as a CDC cooperative agreement suggests the recipient would be expected to meet performance and quality benchmarks, coordinate closely with national and district stakeholders, and report program outputs and outcomes in line with PEPFAR and CDC monitoring expectations.
Frequently Asked Questions (FAQs)
What is the title of this grant opportunity?
The funding opportunity is titled "Supporting the Scale up of Comprehensive HIV/AIDS Prevention Services in the Republic of Uganda under PEPFAR."
Which U.S. agency is offering this funding?
This is a U.S. government public health funding announcement issued by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (HHS-CDC).
What type of funding mechanism is it?
It is a discretionary Cooperative Agreement. That generally means CDC would remain actively involved during implementation through technical collaboration, monitoring, and program guidance, rather than simply issuing funds with minimal involvement.
What is the Funding Opportunity Number (FOA number)?
The Funding Opportunity Number is CDC RFA PS10-10200501SUPP16.
Is this opportunity part of PEPFAR?
Yes. The program is positioned under the broader PEPFAR framework, the U.S. government initiative supporting HIV prevention, care, and treatment in heavily affected countries, including Uganda.
What is the CFDA number or program area referenced?
The announcement is listed within a health funding activity area identified as CFDA 93.067.
What is the main purpose of the award?
The purpose is to support the continuation of voluntary medical male circumcision (VMMC) services and to strengthen the capacity of district-level health facilities to improve diagnosis and treatment of sexually transmitted infections (STIs).
Is this intended to be a new pilot project or a continuation/scale-up?
Based on the description, it is framed as a continuation and scale-up effort rather than a brand-new pilot.
What HIV prevention intervention is specifically supported?
The opportunity supports continued delivery of voluntary medical male circumcision (VMMC) services as a biomedical HIV prevention intervention in Uganda.
Why is VMMC included as part of HIV prevention programming?
The description notes that VMMC is widely used in high-burden settings because it can reduce the risk of heterosexual acquisition of HIV in men when delivered safely and with appropriate counseling and follow-up.
What program components are implied under continued VMMC delivery?
The announcement indicates support for maintaining service availability and the systems needed to deliver circumcisions safely at scale, including demand creation and client flow, quality assurance, and clinical systems for safe service delivery.
What STI-related focus does the opportunity emphasize?
It emphasizes strengthening district health facilities so they can better diagnose and treat STIs as a complement to HIV prevention.
How do STI services connect to HIV prevention in this opportunity?
The description highlights that untreated STIs can increase the likelihood of HIV transmission and acquisition, and that STI services can serve as an entry point for HIV testing, prevention counseling, and linkage to additional services.
What kinds of health facility capacity improvements are suggested for STI diagnosis and treatment?
The opportunity points to strengthening clinical competencies and systems at district facilities. Examples mentioned include improving provider training and adherence to national guidelines, strengthening syndromic management and/or laboratory-supported diagnosis where applicable, ensuring consistent availability of essential STI medicines and commodities, improving documentation and reporting, and reinforcing referral pathways for complicated cases.
What level of the health system is the capacity-building focused on?
The emphasis is on district-level health facilities in Uganda.
What is the broader implementation expectation implied by a CDC cooperative agreement?
The description suggests the recipient would be expected to coordinate closely with national and district stakeholders, meet performance and quality benchmarks, and report program outputs and outcomes in line with PEPFAR and CDC monitoring expectations.
What is the award ceiling (maximum funding amount) listed?
The award ceiling is listed as $1,562,149.
How many awards are expected to be made?
The announcement indicates an expectation of a single award (ExpectedAwards: 1).
What does an expectation of one award suggest about the implementation structure?
It suggests the funding may be intended for one principal implementing partner or for a single prime recipient that could coordinate a broader network of sub-awards or supported facilities.
What is the opportunity category?
The opportunity category is listed as Discretionary.
Who is eligible to apply?
The eligible applicants field is listed as "Others (see text field entitled Additional Information on Eligibility for clarification)," indicating that detailed eligibility criteria were provided in the full announcement rather than being limited to a simple applicant category in the summary.
When was the opportunity posted?
The posting date is December 14, 2015.
What is the creation date listed for the opportunity?
The creation date is also listed as December 14, 2015.
What was the application closing date?
The closing date is February 14, 2016.
How long was the application window based on the dates provided?
Based on the posted date (December 14, 2015) and closing date (February 14, 2016), the application window is roughly two months.
What country is the program focused on?
The work is focused on the Republic of Uganda.
What is the overall theme of this opportunity in one sentence?
It is a targeted PEPFAR-supported HIV prevention investment in Uganda combining continued VMMC scale-up with district-level strengthening of STI diagnosis and treatment services.
Browse more opportunities from the same agency: HHS-CDC
Browse more opportunities from the same category: Health
Next opportunity: Leadership Education in Neurodevelopmental and Other Related Disabilities (LEND)
Previous opportunity: FY16 Rail Safety Innovations Deserving Exploratory Analysis (IDEA) Co-operative Research Program
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS10 10200501SUPP16
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS10 10200501SUPP16) also looked into and applied for these:
| Funding Opportunity |
|---|
| Leadership Education in Neurodevelopmental and Other Related Disabilities (LEND) Apply for HRSA 16 031 Funding Number: HRSA 16 031 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Precision Medicine Initiative Cohort Program Biobank (U24) Apply for RFA PM 16 004 Funding Number: RFA PM 16 004 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Strengthening Community-Based HIV/AIDS Prevention and Care Services in the Underserved Northern and Western Regions of the Republic of Côte d’Ivoire Under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10330501SUPP16 Funding Number: CDC RFA PS10 10330501SUPP16 Agency: HHS-CDC Category: Health Funding Amount: $3,470,000 |
| Novel Genomic Technology Development (R01) Apply for PAR 16 014 Funding Number: PAR 16 014 Agency: HHS-NIH11 Category: Health Funding Amount: $700,000 |
| Nurse Education, Practice, Quality and Retention – Bachelor of Science in Nursing Practicums in Community Settings Program Apply for HRSA 16 066 Funding Number: HRSA 16 066 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Reinforcing HIV Clinical Services within a Network of Public Health Institutions in the Central Plateau and the Lower Artibonite of Haiti under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1712 Funding Number: CDC RFA GH16 1712 Agency: HHS-CDC-CGH Category: Health Funding Amount: $7,500,000 |
| International Centers of Excellence for Malaria Research (U19) Apply for RFA AI 15 056 Funding Number: RFA AI 15 056 Agency: HHS-NIH11 Category: Health Funding Amount: $1,000,000 |
| Strengthening Epidemiology and Strategic Information in the Republic of Zimbabwe under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1675 Funding Number: CDC RFA GH16 1675 Agency: HHS-CDC-CGH Category: Health Funding Amount: $2,010,000 |
| NHLBI Progenitor Cell Translational Consortium Coordinating Center (U24) Apply for RFA HL 16 022 Funding Number: RFA HL 16 022 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Limited Competition - Stimulating Peripheral Activity to Relieve Conditions (SPARC): Foundational Functional Mapping of Neuroanatomy and Neurobiology of Organs (OT2) Apply for RFA RM 15 020 Funding Number: RFA RM 15 020 Agency: HHS-NIH11 Category: Health Funding Amount: $600,000 |
| Service Area Competition Apply for HRSA 16 008 Funding Number: HRSA 16 008 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Protecting the Advances in Polio, Rubella and Measles Elimination: Strengthening Immunization Programs in the Americas. Apply for CDC RFA GH14 140103CONT16 Funding Number: CDC RFA GH14 140103CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| USAID Regional Health Integration to Enhance Services in East Central Uganda (USAID RHITES EC) Apply for RFA 617 16 000001 Funding Number: RFA 617 16 000001 Agency: USAID-UGA Category: Health Funding Amount: $57,000,000 |
| Technical Assistance in Support of HIV Prevention, Care, and Treatment Programs and Other Infectious Diseases that Impact HIV Infected Patients in Support of the President's Emergency Plan for AIDS Relief Apply for CDC RFA PS09 904SUPP Funding Number: CDC RFA PS09 904SUPP Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Rural Health Network Development Planning Program Apply for HRSA 16 017 Funding Number: HRSA 16 017 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| MCH Navigator Program Apply for HRSA 16 043 Funding Number: HRSA 16 043 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Supporting and Maintaining the Surveillance System for Chronic Kidney Disease in the United States Apply for CDC RFA DP16 1604 Funding Number: CDC RFA DP16 1604 Agency: HHS-CDC-NCCDPHP Category: Health Funding Amount: $700,000 |
| Local Non-governmental Partnerships for Sustained Country Leadership in Uganda under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH14 141202CONT16 Funding Number: CDC RFA GH14 141202CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Development and Translation of Medical Technologies to Reduce Health Disparities (SBIR) (R43/R44) Apply for RFA EB 16 001 Funding Number: RFA EB 16 001 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Integrated HIV Prevention Program for the Federal Police Force of Ethiopia Under the President's Emergency Plan for AIDS Relief Apply for CDC RFA PS10 10110SUPP Funding Number: CDC RFA PS10 10110SUPP Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS10 10200501SUPP16", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.